OrbusNeich Medical Group Holdings Limited (HK:6929)
:6929
Want to see HK:6929 full AI Analyst Report?
Total Valuation
OrbusNeich Medical Group Holdings Limited has a market cap or net worth of HK$3.33B. The enterprise value is HK$210.84M.
Market CapHK$3.33B
Enterprise ValueHK$210.84M
Share Statistics
OrbusNeich Medical Group Holdings Limited has 827,968,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding827,968,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OrbusNeich Medical Group Holdings Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 8.41%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)8.41%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee135.58K
Profits Per Employee35.38K
Employee Count1,331
Asset Turnover0.40
Inventory Turnover0.86
Valuation Ratios
The current PE Ratio of OrbusNeich Medical Group Holdings Limited is 9.2. OrbusNeich Medical Group Holdings Limited’s PEG ratio is 1.57.
PE Ratio9.2
PS Ratio2.13
PB Ratio0.93
Price to Fair Value0.93
Price to FCF333.81
Price to Operating Cash Flow20.05
PEG Ratio1.57
Income Statement
In the last 12 months, OrbusNeich Medical Group Holdings Limited had revenue of 180.45M and earned 41.90M in profits. Earnings per share was 0.05.
Revenue180.45M
Gross Profit122.43M
Operating Income39.74M
Pretax Income47.09M
Net Income41.90M
EBITDA42.78M
Earnings Per Share (EPS)0.05
Cash Flow
In the last 12 months, operating cash flow was 21.28M and capital expenditures -9.37M, giving a free cash flow of 11.91M billion.
Operating Cash Flow21.28M
Free Cash Flow11.91M
Free Cash Flow per Share0.01
Dividends & Yields
OrbusNeich Medical Group Holdings Limited pays an annual dividend of HK$0.15, resulting in a dividend yield of 2.7%
Dividend Per ShareHK$0.15
Dividend Yield2.7%
Payout Ratio26.07%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.59
52-Week Price Change12.81%
50-Day Moving Average3.90
200-Day Moving Average4.11
Relative Strength Index (RSI)49.53
Average Volume (3m)176.23K
Important Dates
OrbusNeich Medical Group Holdings Limited upcoming earnings date is Aug 14, 2026, Before Open (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateAug 14, 2026
Ex-Dividend Date―
Financial Position
OrbusNeich Medical Group Holdings Limited as a current ratio of 10.54, with Debt / Equity ratio of 0.95%
Current Ratio10.54
Quick Ratio8.51
Debt to Market Cap<0.01
Net Debt to EBITDA-5.02
Interest Coverage Ratio236.54
Taxes
In the past 12 months, OrbusNeich Medical Group Holdings Limited has paid 5.05M in taxes.
Income Tax5.05M
Effective Tax Rate0.11
Enterprise Valuation
OrbusNeich Medical Group Holdings Limited EV to EBITDA ratio is 3.95, with an EV/FCF ratio of 146.90.
EV to Sales0.94
EV to EBITDA3.95
EV to Free Cash Flow146.90
EV to Operating Cash Flow8.64
Balance Sheet
OrbusNeich Medical Group Holdings Limited has HK$218.68M in cash and marketable securities with HK$3.91M in debt, giving a net cash position of HK$214.76M billion.
Cash & Marketable SecuritiesHK$218.68M
Total DebtHK$3.91M
Net CashHK$214.76M
Net Cash Per ShareHK$0.26
Tangible Book Value Per ShareHK$0.47
Margins
Gross margin is 67.85%, with operating margin of 22.02%, and net profit margin of 23.22%.
Gross Margin67.85%
Operating Margin22.02%
Pretax Margin26.09%
Net Profit Margin23.22%
EBITDA Margin23.71%
EBIT Margin21.80%
Analyst Forecast
The average price target for OrbusNeich Medical Group Holdings Limited is HK$5.30, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$5.30
Price Target Upside19.37% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast9.88%
EPS Growth Forecast5.65%